About Cejemly® (Sugemalimab) The anti-PD-L1 monoclonal antibody sugemalimab was discovered by CStone using the OmniRat® transgenic animal…
Zerpidio (Serplulimab) sold under the brand name 汉斯状 in china. Serplulimab, a recombinant humanised anti-PD-1 monoclonal…
Trametinib is a kinase inhibitor used alone or in combination with dabrafenib to treat patients with cancers…
Dabrafenib is an anti-cancer medication used for the treatment of cancers associated with a mutated version of the…
Osimertinib is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a…
Sotorasib is an anti-cancer medication used to treat non-small-cell lung cancer (NSCLC).It targets a specific mutation,…
Crizotinib is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that…
Sotorasib is in a class of medications called KRAS inhibitors. It works by blocking the action of…
Crizotinib is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that…
Capmatinib is in a class of medications called kinase inhibitors. It works by blocking the action of…
Lorlatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) in adults that…
Brigatinib is a targeted cancer drug treatment for non small cell lung cancer (NSCLC). It is also…
Tepotinib is a kinase inhibitor directed against MET, including variants with exon 14 skipping - it…
Alectinib is a type of cancer growth blocker called a tyrosine kinase inhibitor. It works by…
Lorlatinib, sold under the brand name Pholorla100,Lorbrena in the United States, Canada, and Japan, and Lorviqua…
Lorlatinib, sold under the brand name Lorlatini,Lorbrena among others in the United States, Canada, and Japan,…